Bristol-Myers Squibb Company v Apotex Pty Ltd (No 2) [2010] FCA 901
The costs discretion under s 105(2) of the Patents Act should be exercised so that Otsuka, having sought amendment of its patent claims in the context of ongoing infringement proceedings and thereby exposing Apotex to additional costs, should bear Apotex’s costs reasonably and properly incurred in relation to the amendment application, regardless of Apotex’s ultimate lack of opposition.
- Jurisdiction
- Australia
- Judgment Date
- 23 August 2010
- Procedural Posture
- Patent Infringement and Amendment Application / Costs Decision Following Amendment Application
- Outcome
- Application for costs by Apotex granted against Otsuka.
- Legal Topics
- ['patent Amendment' 'costs Discretion' 'patent Infringement Proceedings']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Patent Infringement and Amendment Application / Costs Decision Following Amendment Application
Legal Issues
- 1 ["Whether the applicant for amendment should pay the respondent's costs of the amendment application in the context of ongoing infringement litigation."]
Ratio Decidendi
The costs discretion under s 105(2) of the Patents Act should be exercised so that Otsuka, having sought amendment of its patent claims in the context of ongoing infringement proceedings and thereby exposing Apotex to additional costs, should bear Apotex’s costs reasonably and properly incurred in relation to the amendment application, regardless of Apotex’s ultimate lack of opposition.
Court Disposition
Application for costs by Apotex granted against Otsuka.
Orders
- ["The second applicant pay the respondent's costs of and incidental to the notice of motion filed by the second applicant on 18 March 2010."]
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment